MDK (Midkine) Gene

A comprehensive overview of the MDK gene, including its genomic context, expression, mutations, and associated diseases.

Gene Information Card

Symbol MDK
Full Name Midkine (neurite growth-promoting factor 2)
Gene Type protein-coding
Chromosomal Location 11p11.2
NCBI Gene ID 4192 ncbi.nlm.nih.gov/gene/4192
Ensembl ID ENSG00000110448
UniProt ID P21741
OMIM ID 162095
HGNC ID 6972
Aliases MK, NEGF2, ARAP, FLJ27379

Description

The MDK gene encodes midkine, a heparin-binding growth factor that promotes cell growth, survival, migration, and angiogenesis. It is involved in neurodevelopment, inflammation, and cancer progression. MDK is overexpressed in many malignancies and is associated with poor prognosis.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Neuroblastoma MDK overexpression promotes tumor growth and angiogenesis via PI3K/Akt and MAPK pathways. PMID: 10445858
Alzheimer disease MDK is upregulated in brain regions affected by Alzheimer disease and may contribute to neuroinflammation and amyloid-beta toxicity. PMID: 12684512
Breast carcinoma MDK expression correlates with tumor progression and metastasis through activation of Notch2 signaling. PMID: 23359680
Wilms tumor MDK is overexpressed in Wilms tumor and may act as an autocrine growth factor. PMID: 10376528

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 12.5 High
Kidney 8.2 Medium
Lung 6.1 Medium
Liver 2.3 Low
Heart 1.8 Low
Cell Line Expression
Cell Line nTPM Notes
SH-SY5Y (neuroblastoma) 15.3 High expression
MCF7 (breast cancer) 9.7 Medium expression
A549 (lung cancer) 7.4 Medium expression
HEK293 (embryonic kidney) 4.1 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1A>G (p.Met1?) missense <0.01% Likely loss of start codon; functional impact unknown
c.214C>T (p.Arg72Trp) missense <0.01% Rare variant; no known disease association
c.382G>A (p.Glu128Lys) missense <0.01% Reported in COSMIC; uncertain significance
Mutation functional classification

Loss of Function (LOF)

No well-characterized loss-of-function mutations reported in MDK.

Gain of Function (GOF)

Overexpression and amplification are common in cancers, suggesting gain-of-function effects.

Dominant Negative (DN)

No dominant-negative mutations described for MDK.

Gene Ontology (GO)

• GO:0008083 - growth factor activity • GO:0008201 - heparin binding
• GO:0005515 - protein binding • GO:0008284 - positive regulation of cell population proliferation
• GO:0043066 - negative regulation of apoptotic process • GO:0001525 - angiogenesis
• GO:0007399 - nervous system development

Pathways

PI3K-Akt signaling pathway (KEGG: hsa04151)
MAPK signaling pathway (KEGG: hsa04010)
Focal adhesion (KEGG: hsa04510)
Proteoglycans in cancer (KEGG: hsa05205)

Protein Summary

Midkine is a 13.4 kDa heparin-binding growth factor composed of two domains: an N-terminal domain and a C-terminal domain, each containing three antiparallel beta-sheets. It is secreted and interacts with cell surface receptors such as LRP1, PTPRZ1, and integrins. Midkine promotes cell survival, migration, and angiogenesis, and is implicated in neurodevelopment, inflammation, and tumorigenesis.

Related Products

Product name Cat.No. Species Gene ID
MDK Knockout HEK293 Cell Line EDJ-KQ50435 Human 4192 Details Get a Quote
MDK Knockout HeLa Cell Line EDJ-KQ53858 Human 4192 Details Get a Quote
MDK Knockout A-549 Cell Line EDJ-KQ62344 Human 4192 Details Get a Quote
MDK Knockout HCT 116 Cell Line EDJ-KQ70816 Human 4192 Details Get a Quote
MDK Knockout A-549-FLUC Cell Line EDC90273 Human 4192 Details Get a Quote
Displaying Records 1 To 5 Of 5 Records
Contact Us
*
*
*
*
How did you hear about us: